Artificial Intelligence (AI) Biocomputing Big Model Market Report 2026

Artificial Intelligence (AI) Biocomputing Big Model Market Overview

• Artificial Intelligence (AI) Biocomputing Big Model market size has reached to $4.38 billion in 2025 • Expected to grow to $11.27 billion in 2030 at a compound annual growth rate (CAGR) of 20.8% • Growth Driver: Rising Demand For Personalized Medicine Driving The Market Growth Due To Advances In Genomic Technologies And Increasing Approval Of Targeted Therapies • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence (AI) Biocomputing Big Model Market?

An artificial intelligence (AI) biocomputing big model is a large-scale artificial intelligence system designed to analyze complex biological and biomedical data, such as genomics, proteomics, and multi-omics datasets. It uses deep learning and generative modeling to predict molecular interactions, identify biomarkers, and support applications such as personalized medicine and drug discovery. The main components of artificial intelligence biocomputing big model include hardware, software, and services. Hardware includes high-performance computing systems and processors used to support complex biological data analysis and large-scale model training. These solutions incorporate models such as large biological models, deep learning frameworks, bioinformatics platforms, and simulation and digital twin software. These solutions are deployed through on-premise, cloud-based, and hybrid models. The various applications involved are genome sequencing, protein structure prediction, and other applications, while the end-use includes pharmaceutical and biotechnology, research institutions and academia, healthcare providers, agricultural firms, environmental and conservation organizations, and government research labs.

What Is The Artificial Intelligence (AI) Biocomputing Big Model Market Growth Forecast?

The artificial intelligence (AI) biocomputing big model market size is expected to see exponential growth in the next few years. It will grow to $11.27 billion in 2030 at a compound annual growth rate (CAGR) of 20.8%. The growth in the forecast period can be attributed to increasing deployment of hybrid AI biocomputing systems, growing demand for personalized medicine applications, rising adoption of large biological models, expansion of cloud-based bioinformatics services, increasing integration with healthcare and agricultural data. Major trends in the forecast period include increasing adoption of cloud-based bioinformatics platforms, rising demand for high-performance computing hardware, growing integration of multi-omics data analysis tools, expansion of simulation and digital twin software applications, rising focus on training and education services for ai biocomputing.

Global Artificial Intelligence (AI) Biocomputing Big Model Market Segmentation

1) By Component: Hardware, Software, Services 2) By Model: Large Biological Models, Deep Learning Frameworks, Bioinformatics Platforms, Simulation And Digital Twin Software 3) By Deployment Mode: On-Premise, Cloud-Based, Hybrid 4) By Application: Genome Sequencing, Protein Structure Prediction, Other Applications 5) By End-User Industry: Pharmaceutical And Biotechnology, Research Institutions And Academia, Healthcare Providers, Agricultural Firms, Environmental And Conservation Organizations, Government Research Labs Subsegments: 1) By Hardware: Processors, Graphics Processing Units, High Performance Computing Systems, Data Storage Systems, Networking And Interconnect Equipment, Artificial Intelligence Accelerators, Bioinformatics Workstations 2) By Software: Model Development And Training Software, Bioinformatics Analysis Software, Simulation And Modeling Software, Data Management And Integration Software, Visualization And Interpretation Software, Workflow And Pipeline Management Software 3) By Services: Consulting And Strategy Services, System Integration Services, Cloud Deployment And Infrastructure Services, Technical Support And Maintenance Services, Data Analysis And Model Optimization Services, Training And Education Services

What Are The Drivers Of The Artificial Intelligence (AI) Biocomputing Big Model Market?

The growing demand for personalized medicine is expected to drive the expansion of the artificial intelligence (AI) biocomputing big model market going forward. Personalized medicine involves tailoring healthcare interventions based on an individual’s genetic, molecular, and clinical characteristics. Advances in genomic and other high-throughput biological technologies have significantly increased the volume and complexity of patient data, creating a need for advanced computational approaches to extract clinically meaningful insights. AI biocomputing big models is a large-scale AI systems capable of analyzing multi-modal datasets such as genomics, proteomics, medical imaging, and electronic health records that support personalized medicine by enabling disease risk prediction, treatment optimization, and therapy customization at scale. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the US food and drug administration approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the growing demand for personalized medicine is driving the growth of the artificial intelligence (AI) biocomputing big model industry. The increase in pharmaceutical research and development (R&D) activities is expected to drive the growth of the AI biocomputing big model market. Pharmaceutical R&D involves systematic efforts by drug manufacturers, biotechnology companies, and research institutions to discover, develop, and optimize new therapies. Rising investment in pharma R&D is driven by the need to improve drug discovery efficiency, reduce development timelines, and address complex diseases, thereby increasing reliance on advanced computational technologies. AI biocomputing big models play a critical role in pharmaceutical R&D by enabling large-scale analysis of multi-omics data, molecular structures, clinical trial data, and real-world evidence. These models support target identification, lead optimization, toxicity prediction, and patient stratification, improving decision-making across the drug development pipeline. For instance, in 2023, according to the Office for National Statistics, a UK-based government agency, the UK government’s net expenditure on research and development increased to £17.4 billion ($22.1 billion), up from £16.1 billion ($20.45 billion) in 2022, representing an 8.2% increase. Therefore, increasing research and development activities are driving the growth of the AI biocomputing big model market. The growing adoption of health monitoring devices is expected to propel the growth of the AI biocomputing big model market going forward. Health monitoring devices are medical or wearable technologies designed to continuously or periodically collect and analyze physiological data to assess an individual’s health status and support timely medical intervention. The increasing adoption of health monitoring devices is driven by the rising prevalence of chronic diseases, as continuous real-time tracking enables early intervention, better disease management, and reduced hospitalization rates. AI biocomputing big models enhance health monitoring devices by analyzing large-scale, multi-parameter physiological data in real time to detect subtle patterns, predict health risks, enable personalized insights, and support proactive, precision-based interventions. For instance, in August 2025, according to the Office of Inspector General, a US-based independent organization, the number of Medicare enrollees using remote patient monitoring increased significantly, reaching nearly 1 million in 2024, which represents a 27% rise compared to 2023. Therefore, the growing adoption of health monitoring devices is driving the growth of the AI biocomputing big model market.

Key Players In The Global Artificial Intelligence (AI) Biocomputing Big Model Market

Major companies operating in the artificial intelligence (AI) biocomputing big model market are Microsoft Corporation, Alibaba Group Holding Limited, Huawei Technologies Co. Ltd., Siemens AG, International Business Machines Corporation, Oracle Corporation, Nvidia Corporation, Generate Biomedicines Inc., Owkin Inc., Nabla Bio Inc., Arzeda Corp., Evozyne Inc., BigHat Biosciences Inc., AI Proteins Inc., Cradle B.V., Profluent Bio Inc., Absci Corporation, Biomatter Designs UAB, Insilico Medicine Ltd., and Variant Bio Inc.

Regional Insights

North America was the largest region in the artificial intelligence (AI) biocomputing big model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Artificial Intelligence (AI) Biocomputing Big Model Market?

The artificial intelligence (AI) biocomputing big model market includes revenues earned by entities providing services such as model training and fine-tuning, cloud-based model hosting and inference, custom model development, and integration into enterprise or research workflows. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The artificial intelligence (AI) biocomputing big model market consists of sales of products such as large-scale biological foundation models, genomic and proteomic prediction engines, molecular simulation AI systems, drug discovery models, and multimodal bio-AI models. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Artificial Intelligence (AI) Biocomputing Big Model Market Report 2026?

The artificial intelligence (ai) biocomputing big model market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (ai) biocomputing big model industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.